Lv3
328 积分 2025-08-25 加入
Elucidating the Role of EGFR L858R in Brain Metastasis Among Patients with Advanced NSCLC Undergoing TKI Therapy
2天前
已完结
Plasma-First Testing in Advanced Lung Cancer: Evidence and Implications
2天前
已完结
Dacomitinib in the treatment of EGFR-mutated non-small cell lung cancer with brain metastases: an open-label, multicenter, phase II study
12天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
22天前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
22天前
已完结
Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non–Small Cell Lung Cancer
22天前
已完结
Brief Report: Safety of Pulse-dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-mutated Non-small Cell Lung Cancer
22天前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases
23天前
已完结
Effectiveness of high-dose third-generation EGFR-tyrosine kinase inhibitors in treating EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastasis
23天前
已完结
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
23天前
已完结
皖公网安备34019202002308
